Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheli Melzer Cohen

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 9, 2017
Improved Glycemic Control Achieved by Switching to Insulin Degludec in Insulin-Treated Patients with Type 2 Diabetes in a Real-World Setting: a Non-interventional, Retrospective Cohort StudyCheli Melzer Cohen, Brian Larsen Thorsted, Michael Lyng Wolden, et al.
Artificial Intelligence in Medicine|July 9, 2022
All-cause mortality prediction in T2D patients with iTirpsPavel Novitski, Cheli Melzer Cohen, Avraham Karasik, et al.
Journal of Diabetes and Its Complications|November 20, 2021
Validating the UK prospective diabetes study outcome model 2 using data of 94,946 Israeli patients with type 2 diabetesXiaohui Zhuo, Cheli Melzer Cohen, Jieling Chen, et al.
Diabetes, Obesity & Metabolism|April 27, 2026
Obesity in Late Adolescence and Healthcare Costs in Young to Mid-AdulthoodCheli Melzer Cohen, Gabriel Chodick, Moshe Leshno, et al.
Current Medical Research and Opinion|April 4, 2018
Dose adjustment of metformin and dipeptidyl-peptidase IV inhibitors in diabetic patients with renal dysfunctionCheli Melzer-Cohen, Avraham Karasik, Philipp J Leuschner, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 1, 2019
A Retrospective Database Study of Liraglutide Persistence Associated with Glycemic and Body Weight Control in Patients with Type 2 DiabetesCheli Melzer-Cohen, Gabriel Chodick, Lise Lotte N Husemoen, et al.
Journal of Gastroenterology and Hepatology|December 4, 2024
Increase Incidence and Prevalence of Eosinophilic Gastrointestinal Disorders in Israel During the Last DecadeAmir Ben-Tov, Cheli Melzer-Cohen, Roni Yahalom, et al.
Cardiovascular Diabetology|August 19, 2021
Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidenceMeir Schechter, Cheli Melzer-Cohen, Aliza Rozenberg, et al.
JMIR Public Health and Surveillance|November 7, 2023
Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control StudyIrit Ben-Aharon, Ran Rotem, Cheli Melzer-Cohen, et al.
Diabetes, Obesity & Metabolism|April 29, 2024
Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuriaAfif Nakhleh, Muhammad Abdul-Ghani, Sivan Gazit, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 9, 2017
Improved Glycemic Control Achieved by Switching to Insulin Degludec in Insulin-Treated Patients with Type 2 Diabetes in a Real-World Setting: a Non-interventional, Retrospective Cohort StudyCheli Melzer Cohen, Brian Larsen Thorsted, Michael Lyng Wolden, et al.
Artificial Intelligence in Medicine|July 9, 2022
All-cause mortality prediction in T2D patients with iTirpsPavel Novitski, Cheli Melzer Cohen, Avraham Karasik, et al.
Journal of Diabetes and Its Complications|November 20, 2021
Validating the UK prospective diabetes study outcome model 2 using data of 94,946 Israeli patients with type 2 diabetesXiaohui Zhuo, Cheli Melzer Cohen, Jieling Chen, et al.
Diabetes, Obesity & Metabolism|April 27, 2026
Obesity in Late Adolescence and Healthcare Costs in Young to Mid-AdulthoodCheli Melzer Cohen, Gabriel Chodick, Moshe Leshno, et al.
Current Medical Research and Opinion|April 4, 2018
Dose adjustment of metformin and dipeptidyl-peptidase IV inhibitors in diabetic patients with renal dysfunctionCheli Melzer-Cohen, Avraham Karasik, Philipp J Leuschner, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 1, 2019
A Retrospective Database Study of Liraglutide Persistence Associated with Glycemic and Body Weight Control in Patients with Type 2 DiabetesCheli Melzer-Cohen, Gabriel Chodick, Lise Lotte N Husemoen, et al.
Journal of Gastroenterology and Hepatology|December 4, 2024
Increase Incidence and Prevalence of Eosinophilic Gastrointestinal Disorders in Israel During the Last DecadeAmir Ben-Tov, Cheli Melzer-Cohen, Roni Yahalom, et al.
Cardiovascular Diabetology|August 19, 2021
Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidenceMeir Schechter, Cheli Melzer-Cohen, Aliza Rozenberg, et al.
JMIR Public Health and Surveillance|November 7, 2023
Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control StudyIrit Ben-Aharon, Ran Rotem, Cheli Melzer-Cohen, et al.
Diabetes, Obesity & Metabolism|April 29, 2024
Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuriaAfif Nakhleh, Muhammad Abdul-Ghani, Sivan Gazit, et al.
Pageof 4